Related Experiment Video
Updated: Aug 25, 2025

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
The Nature, Frequency, and Timing of Pediatric Sedation Adverse Events
Juan P Boriosi1, Micheal L Lasarev2, Peter A Ferrazano1
1Department of Pediatrics, University of Wisconsin, Madison, Wisconsin, USA.
Insights
Most pediatric sedation adverse events (AEs) occur during induction or procedure. Respiratory AEs, including airway obstruction and apnea, frequently begin in these early phases, requiring preparedness during sedation.
Area of Science:
- Pediatric Anesthesiology
- Patient Safety in Sedation
Background:
- Pediatric sedation adverse events (AEs) are documented, but their timing across sedation phases is unclear.
- Understanding AE timing is crucial for optimizing patient safety during pediatric sedation.
Purpose of the Study:
- To describe the nature, frequency, and timing of adverse events (AEs) during pediatric sedation.
- To determine if AEs predominantly occur during the induction phase, as hypothesized.
Main Methods:
- Prospective data collection from 12,012 pediatric sedation encounters (ages 3 months-18 years) between 2013-2020.
- Analysis of patient characteristics, diagnoses, procedures, and AE nature, frequency, and timing.
- Focus on encounters with at least one AE.
Main Results:
- 6.4% of encounters had at least one AE; respiratory AEs were most common (5.4%).
- Respiratory AEs, including partial/complete upper airway obstruction and apnea, most frequently initiated during induction (64.5% of respiratory AEs).
- Laryngospasm and hypoxemia showed similar distribution between induction and procedure phases.
Conclusions:
- The majority of respiratory adverse events during pediatric sedation commence in the induction or procedure phases.
- Sedation teams must be prepared with rescue measures and adequate staffing during induction and procedure phases to manage AEs effectively.
Objectives:
The nature and frequency of pediatric sedation adverse events (AEs) have been well described. However, the timing of specific AEs in induction, procedure, and recovery phase of sedation remains unknown. The objective was to describe the nature, frequency, and timing of AEs. We hypothesized that most AEs would start at the induction phase.
Methods:
We examined prospectively collected data of sedation encounters of children 3 months to 18 years of age, characterized by at least 1 AE, from January 1, 2013 to December 31, 2020. Patient characteristics, primary diagnosis, procedure type, nature, frequency, and timing of AEs were reported.
Results:
Of 12 012 sedation encounters, the mean age was 7.6 (SD = 4.9) years, most (89%) were American Society of Anesthesiologists II risk, the most common diagnosis was hematology/oncology (27.3%) and the most common procedure radiologic (47.8%). At least 1 AE occurred during 765 (6.4%) encounters. Respiratory AEs were most common (n = 645, 5.4% of all encounters) and started more often during induction (64.5% of respiratory AEs). Partial upper airway obstruction was the most common respiratory AE (2.8% of all encounters). Partial (59.4%) and complete (77.3%) upper airway obstruction and apnea (84%) all began more often during induction. Laryngospasm (48.4% vs 46.8%) and hypoxemia (59.3% vs 39%) were similarly distributed between induction and procedure, respectively, though they were rare during recovery.
Conclusions:
Most respiratory events in this cohort started during the induction or procedure phases. The sedation team should be especially prepared to administer rescue maneuvers and allocate staff/resources during these phases.
More Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
11:19Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Related Concept Videos
Parenteral Anesthetics: Overview
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Stages of General Anesthesia